Starling Oncology (STLNW) Capital Expenditures (2021 - 2026)
Starling Oncology's (STLNW) quarterly Capital Expenditures came in at $908000.0 in Q2 2026, down 24.83% on a YoY basis from $1.2 million in Q2 2025, and down 12.86% quarter-over-quarter from $1.0 million in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) Capital Expenditures (2021 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported Capital Expenditures for 6 consecutive years, with $908000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Capital Expenditures fell 24.83% year-over-year to $908000.0; the trailing twelve-month figure through Jun 2026 stood at $3.6 million (up 25.1% YoY), and the FY2025 full-year result was $3.2 million, down 15.54% from the prior year.
- Capital Expenditures slipped to $908000.0 in Q2 2026 per STLNW's latest filing, from $1.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $2.0 million in Q4 2022 and bottomed at -$402000.0 in Q3 2024.
- Historically, Capital Expenditures has averaged $1.1 million across 5 years, with a median of $1.0 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures tumbled 143.23% in 2024, then surged 250.25% in 2025.
- Over 5 years, Capital Expenditures stood at $2.0 million in 2022, then slumped by 56.84% to $861000.0 in 2023, then soared by 103.83% to $1.8 million in 2024, then tumbled by 39.6% to $1.1 million in 2025, then slipped by 14.34% to $908000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $908000.0, $1.0 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 169.82 Mn |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 11.56 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | - |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 15.67 Mn |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | -494,000.00 |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 1.38 Mn |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 6.22 Mn |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | 21.80 Mn |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | 5.36 Mn |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 908,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 908,000.00 |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 604,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 328,000.00 |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | -402,000.00 |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 610,000.00 |
| Dec 31, 2023 | 861,000.00 |
| Sep 30, 2023 | 930,000.00 |
| Jun 30, 2023 | 937,000.00 |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 871,000.00 |
| Sep 30, 2021 | 950,000.00 |